Modern Healthcare Technology Holdings Limited (HK:0919)
:0919
Want to see HK:0919 full AI Analyst Report?
0919 Stock Chart & Stats
HK$0.08
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.08
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.12
Previous CloseN/A
Volume392.00K
Average Volume (3M)71.60K
Market Cap
HK$85.93M
Enterprise Value-HK$132.75M
Total Cash (Recent Filing)HK$301.73M
Total Debt (Recent Filing)HK$62.90M
Price to Earnings (P/E)4.9
Beta-0.11
Next Earnings
Jun 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding904,483,950
10 Day Avg. Volume65,200
30 Day Avg. Volume71,600
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)0.36
Price to Sales (P/S)0.15
P/FCF Ratio0.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved LeverageAn improved debt-to-equity ratio indicates the company has been reducing leverage or growing equity, enhancing financial flexibility. Over 2-6 months this reduces interest burden and bankruptcy risk, enabling more predictable cash allocation to operations, capex, or deleveraging.
Free Cash Flow GrowthSustained free cash flow growth reflects stronger cash conversion from operations, which is durable for funding reinvestment, servicing debt, or absorbing short-term losses. Reliable FCF supports strategic initiatives and provides a buffer while profitability recovers.
Healthy Gross Margins & Stable EquityHealthy gross margins imply enduring product or pricing advantages and room to cover fixed costs, while a stable equity ratio signals a solid asset base. Together these support margin recovery and capital stability over the medium term despite top-line weakness.
Bears Say
Revenue DeclineDeclining revenue growth reduces scale and weakens the firm's ability to cover fixed costs, compressing margins and hindering investment. Over several months this trend can signal demand deterioration or competitive pressure that impedes sustainable recovery and cash generation.
Negative Profitability / ROEPersistent negative net margins and ROE indicate the company is not generating returns on shareholder capital. This undermines reinvestment capacity and shareholder value creation, making funding growth or repairing the balance sheet more challenging over a 2-6 month horizon.
Falling Operating MarginsDeclining EBIT/EBITDA margins point to operational inefficiencies or rising operating costs. Unless structural cost fixes or revenue improvement occur, margin deterioration will persist, limiting free cash flow expansion and constraining strategic flexibility in coming months.
Modern Healthcare Technology Holdings Limited News
0919 FAQ
What was Modern Healthcare Technology Holdings Limited’s price range in the past 12 months?
Modern Healthcare Technology Holdings Limited lowest stock price was HK$0.07 and its highest was HK$0.12 in the past 12 months.
What is Modern Healthcare Technology Holdings Limited’s market cap?
Modern Healthcare Technology Holdings Limited’s market cap is HK$85.93M.
When is Modern Healthcare Technology Holdings Limited’s upcoming earnings report date?
Modern Healthcare Technology Holdings Limited’s upcoming earnings report date is Jun 30, 2026 which is in 11 days.
How were Modern Healthcare Technology Holdings Limited’s earnings last quarter?
Modern Healthcare Technology Holdings Limited released its earnings results on Nov 28, 2025. The company reported HK$0.007 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.007.
Is Modern Healthcare Technology Holdings Limited overvalued?
According to Wall Street analysts Modern Healthcare Technology Holdings Limited’s price is currently Overvalued.
Does Modern Healthcare Technology Holdings Limited pay dividends?
Modern Healthcare Technology Holdings Limited pays a Notavailable dividend of HK$0.013 which represents an annual dividend yield of N/A. See more information on Modern Healthcare Technology Holdings Limited dividends here
What is Modern Healthcare Technology Holdings Limited’s EPS estimate?
Modern Healthcare Technology Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Modern Healthcare Technology Holdings Limited have?
Modern Healthcare Technology Holdings Limited has 904,483,950 shares outstanding.
What happened to Modern Healthcare Technology Holdings Limited’s price movement after its last earnings report?
Modern Healthcare Technology Holdings Limited reported an EPS of HK$0.007 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.351%.
Which hedge fund is a major shareholder of Modern Healthcare Technology Holdings Limited?
Currently, no hedge funds are holding shares in HK:0919
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Modern Healthcare Technology Holdings Limited
Modern Healthcare Technology Holdings Limited operates as an investment holding company, offering a wide array of beauty and wellness services across Hong Kong, mainland China, Singapore, and Australia. The company's activities are structured into two primary divisions: the provision of Beauty and Wellness Services, and the sale of Skincare and Wellness Products. Its service segment delivers a comprehensive range of treatments, including general beauty and facial care, advanced aesthetic procedures (such as bespoke skincare, anti-aging solutions, and referrals for reconstructive plastic surgery), dedicated slimming and weight management programs, and indulgent spa and massage therapies. These spa facilities boast premium amenities, like elegant bathroom furnishings and hydrotherapeutic pools, alongside specialized foot spa, treatment, and massage services. In addition to its services, the firm distributes a diverse collection of skincare and wellness products, marketed under numerous proprietary and external brands, including be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Cellnoc, Mu-lan Spa, Veribe, Castille, Dr Plus, Eclat du teint, and Natural Care. Furthermore, Modern Healthcare Technology Holdings Limited provides supplementary services such as franchising and trademark licensing for beauty and fitness concepts, advertising, maid agency operations, general management support, and food and beverage services. As of March 31, 2022, the company maintained a significant operational footprint, consisting of 30 service centers in Hong Kong, 3 in Mainland China, and 7 in Singapore, complemented by 8 "be Beauty Shop" retail outlets. The corporate headquarters of Modern Healthcare Technology Holdings Limited are situated in Kowloon Bay, Hong Kong.
Technical Analysis
Fu Shou Yuan International Group
―
Perfect Medical Health Management Limited
―
Sino-Life Group Limited
―
Max Sight Group Holdings Limited
―
Shenghui Cleanness Group Holdings Limited
―